Pacific Biosciences of California Newsroom

Bernstein Keeps Their Buy Rating on Pacific Biosciences (PACB)

TipRanksApr 16 06:34 ET

Piper Sandler Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $2

Moomoo NewsApr 15 01:35 ET

Scotiabank Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $2

Moomoo NewsApr 11 01:33 ET

Pacific Biosciences Price Target Maintained With a $3.00/Share by Canaccord Genuity

Dow JonesApr 10 09:37 ET

Pacific Biosciences Is Maintained at Buy by Canaccord Genuity

Dow JonesApr 10 09:37 ET

Pacific Biosciences Analyst Ratings

BenzingaApr 10 09:27 ET

Barclays Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $2

Moomoo NewsApr 10 05:34 ET

TD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Cuts Target Price to $3

Moomoo NewsApr 10 01:36 ET

Scotiabank Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Cuts Target Price to $2

Moomoo NewsMar 26 01:32 ET

Pacific Biosciences Analyst Ratings

BenzingaMar 25 10:26 ET

Cantor Fitzgerald Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $2.5

Moomoo NewsMar 19 01:32 ET

Cantor Fitzgerald Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Cuts Target Price to $2.5

Moomoo NewsMar 10 16:31 ET

Bernstein Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $2

Moomoo NewsMar 4 07:34 ET

Piper Sandler Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Cuts Target Price to $2

Moomoo NewsFeb 20 06:33 ET

Morgan Stanley Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $2

Moomoo NewsFeb 18 08:31 ET

UBS Downgrades Pacific Biosciences of California(PACB.US) to Hold Rating, Cuts Target Price to $1.5

Moomoo NewsFeb 14 20:31 ET

Bernstein Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Cuts Target Price to $2

Moomoo NewsFeb 14 13:31 ET

Pacific Biosciences Analyst Ratings

BenzingaFeb 14 11:42 ET

CCORF Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsFeb 14 07:31 ET

TD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Cuts Target Price to $3.5

Moomoo NewsFeb 13 23:32 ET